Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain
about
Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranesInvolvement of dopamine receptors in binge methamphetamine-induced activation of endoplasmic reticulum and mitochondrial stress pathwaysThe Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsAn open study of tolerability and pharmacokinetics of raclopride extended release capsules in psychiatric patients: a Canadian study.Measurement of density and affinity for dopamine D(2) receptors by a single positron emission tomography scan with multiple injections of [(11)C]raclopride.The decrease of dopamine D₂/D₃ receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB₁ cannabinoid receptors in Parkinson's disease: a preliminary autoradiographic study with the selective dopamine D₂/D₃ anDopamine D2 receptors in the cerebral cortex: distribution and pharmacological characterization with [3H]racloprideLink between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.Mu opioid receptor availability in people with psychiatric disorders who died by suicide: a case control study.Tranylcypromine substituted cis-hydroxycyclobutylnaphthamides as potent and selective dopamine D₃ receptor antagonists.Quantification of small molecule drugs in biological tissue sections by imaging mass spectrometry using surrogate tissue-based calibration standardsIn vitro and ex vivo characterization of (-)-TZ659 as a ligand for imaging the vesicular acetylcholine transporterPotentiation by 2,2'-pyridylisatogen tosylate of ATP-responses at a recombinant P2Y1 purinoceptor.Anatomy of Graft-induced Dyskinesias: Circuit Remodeling in the Parkinsonian StriatumIn vivo imaging of disturbed pre- and post-synaptic dopaminergic signaling via arachidonic acid in a rat model of Parkinson's diseaseBrain dopamine and serotonin differ in regulation and its consequencesPlacebo analgesia: Self-report measures and preliminary evidence of cortical dopamine release associated with placebo response.Rapid changes in d1 and d2 dopamine receptor binding in striatal subregions after a single dose of phencyclidine.Role of Dorsomedial Striatum Neuronal Ensembles in Incubation of Methamphetamine Craving after Voluntary Abstinence.Estimating the effect of endogenous dopamine on baseline [(11) C]-(+)-PHNO binding in the human brain.Pridopidine selectively occupies sigma-1 rather than dopamine D2 receptors at behaviorally active doses.Motivational assessment of mice using the touchscreen operant testing system: effects of dopaminergic drugs.Functional dopamine D2 receptors on rat vagal afferent neurones.Counteraction of the rapid tolerance to 8-OH-DPAT-induced corticosterone secretion in rats by activation of the GABAA receptor-chloride channel complexThe effect of 5-HT1A receptor agonists on locomotor activity in the guinea-pigDopamine Synthesis Capacity is Associated with D2/3 Receptor Binding but Not Dopamine Release.Role of the mesolimbic dopamine system in relief learning.Access to the CNS: Biomarker Strategies for Dopaminergic Treatments.
P2860
Q24563287-5FB65790-3B20-49E3-A65E-1432E55ADED9Q28578719-D08CAE03-6E85-4473-8444-0049975FE8C3Q30486707-109E7DC1-A6D2-4336-B7D2-81CF1F35A038Q33921598-EB2FACFF-9A1D-4CC6-A8ED-9393DC114EADQ34170886-3F08D8C0-3ED6-4921-A87F-1511073D5586Q34267133-DB9B3899-4493-4F6F-A696-24ED38AE1AD3Q34298626-D5F05124-998D-435C-9DF9-7253A2C252A4Q34327236-4448DD5F-DBB8-4971-9E4A-AA594264A528Q34394290-03946073-238F-4DDE-9EAE-725D3901328CQ34435684-867745CD-ABCD-43C1-9749-98F36FC7BCF2Q35149911-FC64F492-123C-47B0-9CA0-DE29F9BE1FAAQ35204649-90593F4C-1C3A-4D35-8D0A-18AD8BE586D0Q35873953-438A3ADF-A5F5-468B-AD3B-6060AF88F9EFQ36034592-71E22BD3-379D-4E71-A54C-35B6918046E9Q36089003-604D127E-6FC5-42E8-9D97-D773E3803749Q36122702-E127F6DC-2789-49E7-A720-EBB13F21067CQ36382450-D8F37C1D-6B72-404F-906C-72FEA2009113Q36600553-A3EE5EB5-4085-4F2F-A826-CFAC291A180DQ37630520-B976D89F-1646-4E7D-A4BD-9BD1AA828AAEQ39656985-6935AB98-1CF9-4BD1-9927-16BA266C43EEQ40753593-41B009A7-109F-4EF5-9525-39F5CF30FAD6Q41779069-D6BD0F24-89AF-431D-8E76-E74B087EEA87Q42113858-D74F29AC-9AEF-4E54-A1D2-9608676A5CC0Q42116745-E67634D7-1034-41F4-B459-631F7299751DQ42210338-8A11ADC8-2318-4AB8-BCD1-44D871959B1BQ46421878-5CBA51D3-C449-4F0B-90CA-BA347297117FQ49912061-25734189-C9BD-4DA4-8709-33AC18D1FCB2Q49949879-9E2642EE-9E95-4318-A55A-AF508D144708
P2860
Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain
description
1985 nî lūn-bûn
@nan
1985 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Specific in vitro and in vivo ...... D-2 receptors in the rat brain
@ast
Specific in vitro and in vivo ...... D-2 receptors in the rat brain
@en
Specific in vitro and in vivo ...... D-2 receptors in the rat brain
@nl
type
label
Specific in vitro and in vivo ...... D-2 receptors in the rat brain
@ast
Specific in vitro and in vivo ...... D-2 receptors in the rat brain
@en
Specific in vitro and in vivo ...... D-2 receptors in the rat brain
@nl
prefLabel
Specific in vitro and in vivo ...... D-2 receptors in the rat brain
@ast
Specific in vitro and in vivo ...... D-2 receptors in the rat brain
@en
Specific in vitro and in vivo ...... D-2 receptors in the rat brain
@nl
P2093
P1476
Specific in vitro and in vivo ...... D-2 receptors in the rat brain
@en
P2093
P304
P407
P577
1985-07-01T00:00:00Z